| Mechanisms Underlying the Waning of Osteoanabolic Therapy Effects in Osteoporosis | Journal of bone and mineral research |  | | 2026 | 9 | 102 |
|
| Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cells | JCI insight | | | 2024 | 124 | 168 |
|
| Reduced sclerostin expression in human atherosclerotic plaques links to ischemic stroke | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | | | 2024 | 89 | 112 |
|
| Primary mouse osteoblast and osteoclast culturing and analysis | STAR protocols | | | 2021 | 428 | 707 |
|
| PDGF receptor signaling in osteoblast lineage cells controls bone resorption through upregulation of csf1 expression | Journal of Bone and Mineral Research |  | | 2020 | 294 | 1 |
|
| Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in mice | Bone | | | 2018 | 471 | 3 |
|
| Suppression of p38α MAPK Signaling in Osteoblast Lineage Cells Impairs Bone Anabolic Action of Parathyroid Hormone | Journal of bone and mineral research | | | 2016 | 397 | 4 |
|
| Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro | BoneKEy reports | | | 2015 | 476 | 7 |
|
| Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency | Endocrinology | | | 2015 | 473 | 3 |
|
| Focus on the p38 MAPK signaling pathway in bone development and maintenance | BoneKEy reports | | | 2015 | 617 | 4 |
|
| Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cells | Molecular and cellular endocrinology | | | 2014 | 692 | 1 |
|
| Predominant role of PDGF receptor transactivation in Wnt3a-induced osteoblastic cell proliferation | Journal of bone and mineral research | | | 2013 | 701 | 552 |
|
| Fibroblast growth factor 2 inhibits up-regulation of bone morphogenic proteins and their receptors during osteoblastic differentiation of human mesenchymal stem cells | Biochemical and biophysical research communications | | | 2012 | 575 | 0 |
|
| The p38α MAPK positively regulates osteoblast function and postnatal bone acquisition | Cellular and molecular life sciences | | | 2012 | 622 | 537 |
|
| Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growth | Cellular physiology and biochemistry | | | 2011 | 662 | 535 |
|
| Discovering the multiple roles of the p38 pathway in bone biology | IBMS boneKEy | | | 2010 | 612 | 1 |
|
